Pågående forskningsprojekt

 

Kliniskt inriktad forskning

 

 CORE 1

  • Longitudinal studies of subjects with MCI (A Nordberg, L Minthon, A Wallin)
  • Familial dementia as a model for sporadic dementia (A Nordberg)
  • Development of a prospective database (M E-Jönhagen, L Minthon, A Wallin)

 

CORE 2

  • Interaction of genetic and non-genetic risk factors for dementing disorders (L Fratiglioni, I Skoog)
  • Exploring potential susceptibility genes for AD in the general population (L Fratiglioni, D Gustafson)
  • Adiposity hormones in dementia (D Gustafson)
  • Harmonisation epidemiology – clinical studies (L Fratiglioni, I Skoog)

 

CORE 3

  • Pre-clinical detection of dementia
  • A looking-glass into the brain of AD in the general population

 

Omvårdnadsforskning och forskning med en teknologisk inriktning

 

 

CORE 4

  • The consequences and possibilities of everyday technology in persons with dementia living at home (L Nygård)
  • IT based assistive technology for cognitive support (L Borell)

 

CORE 5

  • A ward atmosphere of healing; studies of ward atmospheres (PO Sandman)
  • Strain in nursing care of persons with dementia – the development of an assessment scale
    (AK Edberg)
  • Transformation of the physical and psychosocial environment (H Wijk)

 

CORE 6

  • Evaluation of emotional and cognitive impairment using VR technique in combination with MRI 
    (K Bodin)
  • Dementia management supportive system - DMSS (G Bucht)

 

CORE 7

  • Diagnostic process and cognitive tests of dementia in Primary health care (J Marcusson)
  • Economic evaluation of treatments for AD (A Wimo)
  • Cost of brain disorders in Europe (A Wimo)
  • Development of simulation models for neurodegenerative disorders (A Wimo)
  • Willingness to pay for dementia care – a methodological and explorative study (A Wimo)
  • Functional capacity and costs of care (A Wimo)

 

Basalt inriktad forskning

 

CORE 8

  • Modeling Parkinson’s disease - The Mitopark mouse and its implications; Modeling alcohol dehydrogenase risk factors,  OEC and DA cell grafting in the 60HDA model (L Olson)
  • A role for the NOGO receptor (L Olson)
  • Modeling Ageing (NG Larsson)
  • Neuroplaque formation and reversion – a transgenic approach using BACE-deficient mice
    (U Lendahl)
  • Molecular studies of the g-secretase complex using an in vitro system – focus on PSEN (H Karlström)
  • Cytokines, microglia and neurodegeneration; Role of IL-1 system in the brain, Studies on human microglia as test systems for candidate drugs in neurodegenerative disorders such as AD (M Schultzberg)
  • Identifying mechanisms for the association of the APOE polymorphism with neurodegenerative diseases (A Cedazo-Minguez)
  • Role of a new molecule in brain, TRX80 (A Cedazo-Minguez)
  • Transgenic Rat models of AD (E Benedikz)

 

CORE 9

  • Familial dementia as a model for sporadic dementia (C Graff)
  • Exploring potential susceptibility genes for AD in the general population (C Graff)
  • Genetic association studies in AD (C Graff)
  • CYP7B1 promoter polymorphism may influence the risk of AD (C Graff / S Meaney)
  • Genetic variations in normal cognition and ageing (E Eriksson)
  • Genetics of: Parkinsons´ Disease (H Nissbrandt, L Olson), ALS (PM Andersen), ALS and Frontotemporal dementia (C Graff / PM Andersen), MS (J Hillert)
  • Characterization of novel markers of microangiopathy in dementia disorders (N Bogdanovic)

 

 

CORE 10

  • Development of multiparameter CSF biomarkers for neurodegenerative disorders: the candidate biomarker and proteomics approach (K Blennow)
  • Swedish multicenter ADNI-CSF study (K Blennow)
  • Studies on cholesterol 24S-hydroxylase (CYP46) and its product 24S-hydroxycholesterol
    (I Björkhem)
  • A new polymorphism in the HMG-CoA Reductase (HMGCR) promoter and its relationship
    to AD (I Björkhem)

 

Forskning med kombinerad basal/klinisk inriktning

 

CORE 11

  • Treatment of AD transgenic Mmice with donepezil; an MRS study (LO Wahlund)
  • Studies of amyloid depositons and patological processes in AD and MCI – MRI-guided PET measurements and in vitro autoradiography. Pre-studies aiming for multi-tracer molecular imaging application to improve sensitivity (B Långström)
  • Development of a community based brain imaging database (LO Wahlund)

 

CORE 13

  • Decision competence, dementia and ethics (E Sundström, M E-Jönhagen)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 











©Swedish Brain Power|Ansvarig för sidan:Gunilla Johansson@ki.se Uppdaterad av:Helene Wallskär, info@swedishbrainpower.se, 12-apr-10